In conclusion, we found that surface expression of GPR56 was high in LSC‐enriched CD34+38− leukemic cells and correlated with a LSC gene signature in CD34‐positive AML as well as an adverse clinical outcome. Here, CD34 is linked to acute myeloid leukemia.